605 related articles for article (PubMed ID: 19222486)
1. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
[TBL] [Abstract][Full Text] [Related]
2. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
Oki K; Yamane K; Kamei N; Nojima H; Kohno N
Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
[TBL] [Abstract][Full Text] [Related]
3. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
[TBL] [Abstract][Full Text] [Related]
4. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
[TBL] [Abstract][Full Text] [Related]
6. Increase in visfatin after weight loss induced by gastroplastic surgery.
Krzyzanowska K; Mittermayer F; Krugluger W; Kopp HP; Schernthaner G
Obesity (Silver Spring); 2006 Nov; 14(11):1886-9. PubMed ID: 17135602
[TBL] [Abstract][Full Text] [Related]
7. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
[TBL] [Abstract][Full Text] [Related]
9. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.
Chen CC; Li TC; Li CI; Liu CS; Lin WY; Wu MT; Lai MM; Lin CC
Metabolism; 2007 Sep; 56(9):1216-20. PubMed ID: 17697864
[TBL] [Abstract][Full Text] [Related]
10. Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls.
Nassis GP; Papantakou K; Skenderi K; Triandafillopoulou M; Kavouras SA; Yannakoulia M; Chrousos GP; Sidossis LS
Metabolism; 2005 Nov; 54(11):1472-9. PubMed ID: 16253636
[TBL] [Abstract][Full Text] [Related]
11. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
[TBL] [Abstract][Full Text] [Related]
12. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
[TBL] [Abstract][Full Text] [Related]
13. Visfatin, low-grade inflammation and body mass index (BMI).
Samara A; Pfister M; Marie B; Visvikis-Siest S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):568-74. PubMed ID: 18248642
[TBL] [Abstract][Full Text] [Related]
14. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
15. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
[TBL] [Abstract][Full Text] [Related]
16. Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects.
Schindler K; Haider D; Wolzt M; Rieger A; Gmeinhart B; Luger A; Nowotny P; Ludvik B
Eur J Clin Invest; 2006 Sep; 36(9):640-6. PubMed ID: 16919047
[TBL] [Abstract][Full Text] [Related]
17. Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal.
Lin SY; Huang SC; Sheu WH
Metabolism; 2010 Feb; 59(2):195-9. PubMed ID: 19765779
[TBL] [Abstract][Full Text] [Related]
18. Visfatin levels in prepubertal children born small or large for gestational age.
Giapros VI; Kiortsis DN; Evagelidou EN; Challa AS; Cholevas VK; Siomou EC; Bairaktari ET; Andronikou SK
Horm Metab Res; 2012 Feb; 44(2):135-9. PubMed ID: 22314334
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
Gen R; Akbay E; Muslu N; Sezer K; Cayan F
Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
[TBL] [Abstract][Full Text] [Related]
20. Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers.
Bo S; Ciccone G; Baldi I; Gambino R; Mandrile C; Durazzo M; Gentile L; Cassader M; Cavallo-Perin P; Pagano G
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):423-30. PubMed ID: 19073361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
